home / stock / crmd / crmd news


CRMD News and Press, CorMedix Inc. From 08/10/22

Stock Information

Company Name: CorMedix Inc.
Stock Symbol: CRMD
Market: NYSE
Website: cormedix.com

Menu

CRMD CRMD Quote CRMD Short CRMD News CRMD Articles CRMD Message Board
Get CRMD Alerts

News, Short Squeeze, Breakout and More Instantly...

CRMD - Notable earnings before Thursday's open

Major earnings expected before the bell on Thursday include: Arrival ( ARVL ) Brookfield Asset Management ( BAM ) Cardinal Health ( CAH ) Hanesbrands ( HBI ) Himax Technologies ( HIMX ) For further details see: Notable earnings before Thur...

CRMD - Why CorMedix Stock Was Plummeting on Tuesday

Biotech stocks are notoriously volatile, and reinforcing this on Tuesday was the performance of the clinical-stage company CorMedix (NASDAQ: CRMD) . A key pipeline product was again rejected by a top regulator, and as a result the shares were in free fall. They closed the day down m...

CRMD - PHAT and SKYX among mid-day movers

Gainers: BBQ Holdings ( BBQ ) +46% . Verona Pharma ( VRNA ) +41% . Mersana Therapeutics ( MRSN ) +31% . SAI.TECH Global ( SAI ) +30% . Atara Biotherapeutics ( ATRA ) +28% . PubMatic ( PUBM ) +24% . RumbleON ( RM...

CRMD - Verona, Mersana top healthcare gainers; CorMedix, Quanterix lead losers' pack

Gainers: Verona Pharma VRNA +87% . Mersana Therapeutics ( MRSN ) +38% . GoodRx Holdings ( GDRX ) +19% . Atara Biotherapeutics ( ATRA ) +22% . Heron Therapeutics HRTX +16% . Losers: CorMedix ( CRMD ) -56% . Qu...

CRMD - Novavax, ironSource, CarGurus among premarket losers' pack

CorMedix CRMD -61% after FDA again rejects CorMedix's application for lead candidate DefenCath . Turtle Beach HEAR -32% on Q2 earnings miss . Novavax NVAX -31% on Q2 earnings release . Medicenna Therapeutics MDNA -29% on launch of units offeri...

CRMD - FDA again rejects CorMedix's application for lead candidate DefenCath, shares sink ~60%

CorMedix ( NASDAQ: CRMD ) on Monday said its new drug application for its antibacterial and antifungal solution DefenCath had been rejected by the U.S. FDA for a second time, sending its shares plunging 60.1% to $3 after hours. The second rejection of the new drug ...

CRMD - CorMedix Inc. Announces Regulatory and Manufacturing Updates

BERKELEY HEIGHTS, N.J., Aug. 08, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced updates related to the ...

CRMD - CorMedix Inc. To Report Second Quarter 2022 Financial Results and Provide a Corporate Update on August 11

BERKELEY HEIGHTS, N.J., Aug. 01, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it will report...

CRMD - CRMD, CALA and TBLT among mid-day movers

Gainers: Direct Digital Holdings ( DRCT ) +81% . ToughBuilt Industries ( TBLT ) +54% . Stronghold Digital Mining ( SDIG ) +42% . Calithera Biosciences ( CALA ) +27% . CorMedix ( CRMD ) +23% . Allakos ( ALLK ) +22% ...

CRMD - NASDAQ: CRMD Investor Notice: Update in Lawsuit against CorMedix Inc. announced by the Shareholders Foundation

SAN DIEGO, July 06, 2022 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in shares of the CorMedix Inc. (NASDAQ: CRMD). Investors, who purchased shares of CorMedix Inc. (NASDAQ: CRMD) prior to July 2020 and c...

Previous 10 Next 10